ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
87.495
-0.21%
Bitcoin
62,652.75
-0.71%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Scinai Immunotherapeutics Ltd (SCNI) Quote

Scinai Immunotherapeutics Ltd

Scinai Immunotherapeutics Ltd (SCNI)

NASDAQ
0.457832
0.00783
(1.74%)
Closed April 28 4:00PM
Delayed by 15 minutes
0.45
-0.00783
(-1.71%)
After Hours: 7:11PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.45
Bid
0.4011
Ask
0.4589
Volume
4,460
0.45 Day's Range 0.483
0.00 52 Week Range 0.00
Market Cap
-
Previous Close
0.45
Open
0.483
Last Trade
128
@
0.45
(formt)
Last Trade Time
Financial Volume
$ 2,069
VWAP
0.463994
Average Volume (3m)
-
Shares Outstanding
-
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Scinai Immunotherapeutics Ltd

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic ... BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Coml Physical, Biologcl Resh
Website
www.biondvax.com
Headquarters
Jerusalem, Jerusalem, Isr
Founded
2012
Scinai Immunotherapeutics Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SCNI. The last closing price for Scinai Immunotherapeutics was $0.45. Over the last year, Scinai Immunotherapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Scinai Immunotherapeutics currently has 0 shares outstanding.

SCNI Latest News

More News

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG PR Newswire JERUSALEM, April 10...

April 10 2024
PR Newswire (US)

Biotech Rips Following Five-Year Master Service Agreement Release

There is something about biotech companies that seems to get everyone excited in the penny stock realm. Whether it’s the potential for major FDA approval announcements or To read the full...

April 08 2024
AllPennyStocks.com

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services PR Newswire JERUSALEM, April 8, 2024 JERUSALEM, April 8, 2024...

April 08 2024
PR Newswire (US)

Scinai leadership to attend BIO-Europe Spring 2024

Scinai leadership to attend BIO-Europe Spring 2024 PR Newswire JERUSALEM, March 12, 2024 Showcasing Company's cGMP biologics CDMO and innovative NanoAb pipeline JERUSALEM, March 12, 2024...

March 12 2024
PR Newswire (US)

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 PR Newswire JERUSALEM, Feb. 29, 2024 JERUSALEM, Feb. 29, 2024 /PRNewswire/ -- Scinai Immunotherapeutics...

February 29 2024
PR Newswire (US)

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

Scinai Welcomes Liat Halpert as Head of Business Development and Sales PR Newswire JERUSALEM, Feb. 13, 2024 JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI...

February 13 2024
PR Newswire (US)

Form F-3 - Registration statement by foreign private issuers

January 30 2024
Edgar (US Regulatory)

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize PR Newswire JERUSALEM, Jan. 25, 2024 JERUSALEM, Jan. 25, 2024 /PRNewswire/...

January 25 2024
PR Newswire (US)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

January 24 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
zerosnoop zerosnoop 3 minutes ago
If authorities don't believe lies told by uneducated fools with a low IQ, compulsive liar's, cowards, grubs, tax cheats, paid bashers or fraudsters, nor do I

The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued Lice
QSEP
newmedman newmedman 5 minutes ago
ahh c'mon, haven't you ever lived? In MI I would have been the life of the party as long as it was accompanied by the eye popping bloody marys' with our neighbor's newest hot sauce... don't be shy like me, insert yourself.
littlejohn littlejohn 5 minutes ago
SDOW or SQQQ are decay plays that

only get used short term periods...

And the calls lose just as easy with

less money outlay...

Some calls might get the bid hit on

Monday on SDOW if futures hold

up until the op
SDOW SQQQ
zerosnoop zerosnoop 5 minutes ago
So who from the London syndicate is SHORT big time on QS ? It's not too late to cover. The clock is ticking....

What about the London naked short syndicate shares ? No, there’s no such thing as naked shorting, nah. Ears pop to even the mention of it. Lmfao.

What a bait
QSEP
Mutat Mutat 6 minutes ago
Just to keep up to date on the Dr. I feel we have lost out because of Harry and his buddy.

#AdnexusBiotechnologies has recently added a valuable asset to its therapeutics portfolio. #Sanctum Therapeutics' HIV capsid inhibitor has shown promising results in neutralizing HIV, making it
ENZC
zerosnoop zerosnoop 7 minutes ago
NAKED SHORT SELLING gets reported differently & isn't part of Finra reporting. Experts that know their job tell me there is a HUGE SHORT position in QS from the London syndicate.

This is why I do my own d/d. I only take advice from professionals who know what they are talking about &
QSEP
Zorax Zorax 8 minutes ago
Have to wonder how tied up n-t-ek and n-t-gl are when it comes to legal court stuff.
NTGL
Mutat Mutat 10 minutes ago
In this agreement it states the shareholders will get dividend stocks but the yearly report states on page four that common shares will not get the divi shares.

Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
This agreement transferred ownership
ENZC
ddls ddls 10 minutes ago
stop posting you're giving investors the wrong impression about this junk POS stock.
BIEL
Juststoppingby Juststoppingby 11 minutes ago
Quote from 10-K filing.

“However, there can be no assurances that we will not need additional funding in the future or that our current cash position will be sufficient to fund any future plans to accelerate our commercialization efforts.”

That would be money well spent
CRTG
janice shell janice shell 14 minutes ago
Sounds terrific!!
janice shell janice shell 15 minutes ago
I've watched most of the specials, but I've never watched the movie. No idea why not; it's on all the time.
Sirpeter Sirpeter 16 minutes ago
What team?...it's a homeless vagrant twirling a here's coffee sign pretending to be a CEO? Lol

Be out by EOD tomorrow before this gets dumped
CBIA
blackhawks blackhawks 17 minutes ago
Ernst & Noem Veterinary Medicine has a nice ring to it.
pothen pothen 17 minutes ago
Quote: "I for One want this to Rise by May 1st to .05, he has Shared a lot more than those that have Nothing Positive to Say and will be Missed! I for One think he should Stay Regardless because I did not see any Naysayer take the Other-Side of that Bet!"

What bet? Your boy Benny made
AABB
Elroy Jetson Elroy Jetson 17 minutes ago
What a douchebag

Musk looks to weak Chinese officials in order to approve half-blind self-driving Tesla taxis.

“Musk made a surprise weekend trip to Beijing to meet with a host of high-ranking Chinese government officials, including Chinese Premier Li Qiang, with a lase
Kool Aid Man Kool Aid Man 17 minutes ago
john bought the shell strickland is long gone!--Park bought the shell from who...with what? And you know this how? All I know is official filings with the SOS show they were made by convicted criminal/ permanently barred Randall Goulding. Explain why he is acting on behalf of SPOOZ in defiance of th
SPZI
newmedman newmedman 17 minutes ago
there's a display here in town for the titanic, like a pop up museum. My girl wants to go but I won't, I told her that we have better time to spend together and we already know what happened.. I'm not sure if that pisses her off or not but whatever, she's her own woman and can go if she
skydog526 skydog526 19 minutes ago
64 Colon clonk is inevitable other than your clown town demonic channel. The question to the answer is why spend so much time on only one failure in life.
BTCUSD
gitreal gitreal 20 minutes ago
And your Huggy/HomeBrew and rbtree Ids have cursed me and a
few others out.

Did they? How rude....
AABB
INEEDMONEY INEEDMONEY 21 minutes ago
Lmao there are a lot of otc pink current sub penny stocks out there. This dosent make it similar . I mean SS IS NOT TO FAR AWAY! I hope I am wrong and this baby runs hard
HIRU
TRAPPER JIM TRAPPER JIM 21 minutes ago
I’ll check it out thanks. Yes I had a tetanus shot a few years ago. Pretty sure it’s still good. That fish just kept flipping and flopping and somehow that hook got stuck clear through my hand up to the curved part. LOLOLOLOLOLOL
Cameron12221 Cameron12221 21 minutes ago
I get where you come from based on the OTC and people who are a little over hyped.

Some of the bigger selling factors to me were that they worked with many universities and in the later years Johns Hopkins vet division.

Probably the 2nd biggest factor to me was that th
RDGL

Your Recent History

NASDAQ
SCNI
Scinai Immunotherapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved